Abstract 4260: PT886, an anti-claudin18.2/anti-CD47 bispecific antibody constructed with the PACbody and SPECpair technology platforms, exhibits robust anti-tumor activity in a pancreatic cancer xenograft modelJack Li, Hui Zou, Erin Ramsey et al.|Cancer Research|2022Cited by 7